Anbio Biotechnology (NASDAQ:NNNN) Trading Up 11.3% – Here’s Why

Posted by Casey Walker on May 24th, 2026

Shares of Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) were up 11.3% on Friday . The company traded as high as $34.96 and last traded at $33.6550. Approximately 16,692 shares changed hands during mid-day trading, a decline of 63% from the average daily volume of 44,863 shares. The stock had previously closed at $30.25.

Analysts Set New Price Targets

Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Check Out Our Latest Analysis on Anbio Biotechnology

Anbio Biotechnology Trading Up 7.5%

The stock’s 50 day moving average price is $26.22.

Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) last released its earnings results on Tuesday, April 7th. The company reported $0.03 EPS for the quarter.

Anbio Biotechnology Company Profile

(Get Free Report)

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.